Skip to main content

Table 4 Extracellular vesicles derived from stem cells promote angiogenesis in stroke

From: Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases

EVs source

EVs type

EVs isolation

Experimental model (target cells/animal models)

Functional cargo

Molecules/pathways activated

Key functions/downstream genes

Reference

BM-MSCs

Unclear

0.22-μm pore membrane filtration

PEG ultrafiltration

Centrifugation

In vivo (male C57BL6 mice/MCAO model)

/

/

Formation of new endothelial cells

Doeppner et al. [12]

BM-MSCs

Exosomes

0.2-μm pore membrane filtration

Differential centrifugation

Ultracentrifugation

In vivo (male Wistar rats/MCAO model)

/

/

Promote angiogenesis after stroke

Xin et al. [118]

ADSCs

Exosomes

Total exosome isolation kit

In vitro (BMECs)

In vivo (male Wistar rats/MCAO model)

miR-181b-5p

TRPM7 axis

TRPM7↓→HIF-1α and VEGF↑ TIMP3↓

Yang et al. [119]

  1. Abbreviation: BM-MSCs bone marrow-mesenchymal stem cells, ADSCs adipose-derived stem cells, MCAO middle cerebral artery occlusion model, TRPM7 transient receptor potential melastatin 7, HIF-1a hypoxia-inducible factor 1 alpha, VEGF vascular endothelial growth factor